and sodium pyruvate to maintain the characteristic morphology, motility, and viability of the Campylobacter cultures (4) * Corresponding author. and to increase CTON production (22) . Sodium citrate, at molar concentrations equivalent to those of the iron compound, was added to the broth phase to prevent iron precipitation.
After incubation, the cell-free supematants were prepared by centrifugation of the broth phase at 10,000 x g for 30 min and membrane filtration (Millex; pore size, 0.22 ,um; Millipore) of the supernatant.
Toxin assays were conducted at 37°C under 5% CO2 in a humidified CO2 incubator (Forma Scientific). Y-1 monolayers were propagated with Ham's F-10 medium with L-glutamine (M.A. Bioproducts), supplemented with 14% fetal calf serum (Delta). HeLa cells were maintained in Eagle's minimal essential medium with Earle salts and L-glutamine, supplemented with 10% fetal calf serum. The assay for CTON was done on Y-1 cells according to published procedures (14) . In this assay, .50% cell rounding was considered positive for CTON (15) . The CTOX assay was conducted with HeLa cells according to the dye release method of Gentry and Dalrymple (8) . A .50% cell detachment was regarded as positive for CTOX.
For neutralization (16) , the cell-free supernatants of CTON-positive cultures were incubated for 1 h at 37°C with equal volumes of a 10-fold serial dilution of 1-,ug/ml cholera antitoxin (Swiss Serum Institute) before addition to the Y-1 monolayers in a microtiter plate. Antiserum against CTOX was not available.
The results are summarized in Table 2 . All cultures were confirmed as Campylobacter strains. They were said to be Campylobacter jejuni-Campylobacter coli if they showed typical darting motility in brucella broth and were suscepti- Hip., hippurate hydrolysis; Nal., resistance (R) or susceptibility (S) to nalidixic acid; Cep., resistance (R) or susceptibility (S) to cephalothin; Ox., oxidase production; Cat., catalase production; H2S, H2S detected on lead acetate strips from triple sugar iron agar cultures. Symbols: +, positive; -, negative; (+), weakly positive. ble to nalidixic acid (30-,ug disk) and resistant to cephalothin (30-,ug disk) . On the basis of the hippurate hydrolysis test (11) , there were 15 C. jejuni isolates and 7 C. coli isolates. Strain 85.86 cross-reacted with a DNA probe against C. jejuni-C. coli (in another experiment) and was considered to be a C. coli strain. The two hippurate-positive, nalidixic acid-resistant strains were grouped with the C. jejuni isolates (3) . Strains IP383 and 136SP were the positive and negative controls, respectively. The identity of CTON was confirmed by neutralization.
From Table 2 , it is evident that 19 (86%) of our isolates were toxigenic: 12 (55%) produced one toxin type, and 7 (32%) produced both types. Seventeen (77%) were positive for CTON, and 9 (41%) were positive for CTOX. Johnson and Lior found concurrent production of CTON and CTOX in 53% (13) to 67% (12) of C. jejuni-C. coli isolates. Their incidence of toxin-negative isolates varied between 5% (12) and 14% (13), comparable to our 14%.
Our finding that 67% of C. jejuni strains were positive for CTON is comparable to the 75% incidence of CTONpositive strains found by Ruiz-Palacios et al. (28) in Mexico and the 70% incidence reported by Johnson and Lior (14) in Canada. The South African CTON incidence figure is, however, more than double that found for CTON in South India (32%) (21) . All 7 of our C. coli isolates produced CTON. Similarly, Johnson and Lior (14) also reported a high CTON incidence (83%) in 131 isolates.
We found CTOX in 47% of our C. jejuni isolates and in 29% of the C. coli isolates. This is a considerably lower incidence than the 69 and 78% incidence, respectively, found by Johnson and Lior (14) . In a smaller study by (14) .
